GNC-035

· Sichuan Baili Pharmaceutical Co., Ltd.

Drug timelines are a Plus or Pro feature.

5 regulatory and trial events tracked for GNC-035, covering 2024-07-18 to 2025-10-01. Get the full timeline:

Most recent: Clinical Trial Update: A Study of GNC-035 in Relapsed or Refractory Non-Hodgkin 's Lymphoma and Other Hematological Malignancies [Phase 1, Phase 2]

See pricing